We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
VanEck Pharmaceuticals ETF | NASDAQ:PPH | NASDAQ | Exchange Traded Fund |
Price Change | % Change | Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 93.23 | 92.60 | 93.74 |
High Price | Low Price | Open Price | Traded | Last Trade |
---|---|---|---|---|
4 | 12:05:48 |
Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
---|---|---|---|---|---|---|
25 Jun 2024 | 93.23 | 0.20 | 0.21% | 92.95 | 93.44 | 108,336 |
24 Jun 2024 | 93.03 | 0.87 | 0.94% | 92.62 | 93.26 | 208,648 |
21 Jun 2024 | 92.16 | 0.24 | 0.26% | 91.85 | 92.22 | 82,122 |
20 Jun 2024 | 91.92 | 0.17 | 0.18% | 91.53 | 92.27 | 181,839 |
18 Jun 2024 | 91.755 | 0.13 | 0.15% | 91.55 | 92.04 | 98,574 |
17 Jun 2024 | 91.62 | -0.06 | -0.07% | 91.24 | 91.68 | 150,699 |
14 Jun 2024 | 91.68 | -0.25 | -0.27% | 91.28 | 91.87 | 227,897 |
13 Jun 2024 | 91.93 | -0.11 | -0.12% | 91.30 | 92.06 | 292,647 |
12 Jun 2024 | 92.04 | -0.24 | -0.26% | 91.85 | 92.97 | 83,992 |
11 Jun 2024 | 92.28 | -0.38 | -0.41% | 91.58 | 92.519 | 103,357 |
10 Jun 2024 | 92.66 | 0.41 | 0.44% | 91.58 | 92.669 | 78,433 |
07 Jun 2024 | 92.25 | 0.13 | 0.14% | 91.92 | 92.53 | 118,042 |
06 Jun 2024 | 92.12 | 0.35 | 0.38% | 91.5709 | 92.22 | 102,900 |
05 Jun 2024 | 91.77 | 0.60 | 0.66% | 91.19 | 91.86 | 276,240 |
04 Jun 2024 | 91.17 | 0.45 | 0.50% | 90.58 | 91.27 | 289,605 |
03 Jun 2024 | 90.72 | 0.26 | 0.29% | 90.115 | 91.0602 | 85,673 |
31 May 2024 | 90.46 | 1.32 | 1.48% | 89.58 | 90.48 | 309,470 |
30 May 2024 | 89.14 | 0.45 | 0.51% | 88.79 | 89.42 | 71,064 |
29 May 2024 | 88.69 | -0.19 | -0.21% | 88.28 | 88.70 | 242,913 |
28 May 2024 | 88.88 | -0.99 | -1.10% | 88.61 | 89.69 | 139,423 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions